Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients with Endometriosis.

Stopped early · Not applicable · Has a placebo group

Conditions studied: Endometriosis, Dyspareunia, Pelvic Pain

In brief

Dyspareunia is defined as pain with penetrative sexual intercourse. Women with endometriosis have a nine-fold increased risk of dyspareunia, when compared to the general female population. A prospective single-blinded randomized controlled trial will be performed evaluating the change in pelvic pain and sexual satisfaction scores from baseline to 6 weeks after treatment with transvaginal photobiomodulation therapy or sham therapy. Treatment will involve 9 planned treatment sessions over 3-4 weeks. 40 women will be included in the study.

Key facts

Study ID

NCT05540353

Run by

Medstar Health Research Institute

People needed

6

Starts

2023-05-02

Expected to finish

2024-07-01

Last updated by the study team

2025-02-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Proficient English-speaking females
• Pathology proven endometriosis, >6 weeks from prior pelvic surgery
• Current dyspareunia

You may not qualify if…

• Unable to comply with study protocol
• Pregnant or attempting to become pregnant
• History of or active treatment for pelvic malignancy
• Currently taking light-sensitizing drugs

Where it is running

• MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States
• MedStar Lafayette Center — Washington D.C., District of Columbia, United States
• MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States
• MedStar Mitchellville Clinic — Mitchellville, Maryland, United States
• MedStar Rockville Clinic — Rockville, Maryland, United States
• MedStar McLean Clinic — McLean, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.